Skip to main content
SpringerLink
Log in

Future Directions in Radioembolization

  • Chapter
Liver Radioembolization with 90Y Microspheres

Part of the book series: Medical Radiology ((Med Radiol Diagn Imaging))

  • 1038 Accesses

Abstract

Radioembolization with yttrium-90 (90Y) micro- spheres represents an innovative approach that has gained increasing awareness and clinical use over the past 5-10 years. The minimal toxicity of radioembolization and the ability to discharge the patient on an outpatient basis make the therapy an attractive alternative in the treatment of primary and metastatic liver malignancies. Patients are able to resume normal activities shortly following treat- ment, with minimal side effects, in contrast to the post-embolization syndrome often associated with current chemoembolic techniques.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Thera Sphere (2004) TheraSphere Yttrium-90 micro-spheres package insert, MDS Nordion, Kanata, Canada

    Google Scholar 

  2. SIRTeX Medical (2004) SIR-Spheres Yttrium-90 micro-spheres package insert, SIRTeX Medical, Lane Cove, Australia

    Google Scholar 

  3. Flynn WJ (1967) The treatment of pulmonary metastases with microspheres of yttrium 90. Minerva Med 58:4498–500

    PubMed  CAS  Google Scholar 

  4. Greene WM (1963) Embolization of dog prostates with yttrium-90 microspheres. J Urol 90:451–457

    PubMed  CAS  Google Scholar 

  5. Wollner I, Knutsen C, Smith P, Prieskorn D, Chrisp C, Andrews J, Juni J, Warber S, Klevering J, Crudup J, Ensminger W (1988) Effects of hepatic arterial yttrium 90 glass microspheres in dogs. Cancer 61:1336–1344

    Article  PubMed  CAS  Google Scholar 

  6. Wollner IS, Knutsen CA, Ullrich KA, Chrisp CE, Juni JE, Andrews JC, Tuscan MJ, Stetson PL, Ensminger WD (1987) Effects of hepatic arterial yttrium-90 microsphere administration alone and combined with regional bro-modeoxyuridine infusion in dogs. Cancer Res 47:3285–3290

    PubMed  CAS  Google Scholar 

  7. Ariel I (1965) Intra-arterial injection of radioactive microspheres of ceramic in the treatment of malignant tumors. Indications and clinical results. Minerva Med 56:2030–2037

    PubMed  CAS  Google Scholar 

  8. Ariel IM (1965) Treatment of inoperable primary pancreatic and liver cancer by the intra-arterial administration of radioactive isotopes (Y90 radiating microspheres). Ann Surg 162:267–278

    Article  PubMed  CAS  Google Scholar 

  9. Ariel IM, Flynn W, Pack GT (1967) Current possibilities of radioactive ceramic microspheres labeled with yttrium 90. Minerva Med 58:4496–4498

    PubMed  CAS  Google Scholar 

  10. Ariel IM, Padula G (1973) Irradiation of the spleen by the intra-arterial administration of 90 yttrium microspheres in patients with malignant lymphoma. A preliminary report. Cancer 31:90–96

    CAS  Google Scholar 

  11. Simon N, Siffert R, Baron MG, Mitty HA, Rudavsky A (1968) Preoperative irradiation of osteogenic sarcoma with intra-arterially injected yttrium-90 microspheres. Case report. Cancer 21:453–455

    Article  PubMed  CAS  Google Scholar 

  12. Jaffe R, Simon N (1968) Treatment of brain tumors with internally deposited yttrium 90. Neurology 18:309

    PubMed  CAS  Google Scholar 

  13. Pandey U, Bapat KN, Samuel G, Sarma HD, Chaudhari PR, Dhami PS, Kannan R, Venkatesh M (2005) Evaluation of 90Y phosphate particles as a possible radiation synoviorthesis agent. Nucl Med Commun 26:459–463

    Article  PubMed  CAS  Google Scholar 

  14. Sojan S, Bartholomeusz D (2005) Cutaneous radiation necrosis as a complication of yttrium-90 synovectomy. Hell J Nucl Med 8:58–59

    PubMed  Google Scholar 

  15. Dunn AL, Manco-Johnson M, Busch MT, Balark KL, Abshire TC (2005) Leukemia and P32 radionuclide synovectomy for hémophilie arthropathy. J Thromb Hae-most 3:1541–1542

    Article  CAS  Google Scholar 

  16. Chadzopoulos D, Badiavas K (2005) Complications in 90Y radiation synovectomy. Hell J Nucl Med 8:134; author reply 134

    PubMed  Google Scholar 

  17. Sheppeard H, Aldin A, Ward DJ (1981) Osmic acid versus yttrium-90 in rheumatoid synovitis of the knee. Scand J Rheumatol 10:234–236

    Article  PubMed  CAS  Google Scholar 

  18. Chamberlain MN, Gray BN, Heggie JC, Chmiel RL, Bennett RC (1983) Hepatic métastases-a physiological ap-proach to treatment. Br J Surg 70:596–598

    Article  PubMed  CAS  Google Scholar 

  19. Mantravadi RV, Spigos DG, Tan WS, Felix EL (1982) Intraarterial yttrium 90 in the treatment of hepatic malignancy. Radiology 142:783–786

    PubMed  CAS  Google Scholar 

  20. Mantravadi RV, Spigos DG, Karesh SM, Pavel DG, Grady EG, Capek V (1983) Work in progress: intra-arterial P-32 chromic phosphate for prevention of postoperative liver métastases in high-risk colorectal cancer patients. Radiology 148:555–559

    PubMed  CAS  Google Scholar 

  21. Hafeli UO, Casillas S, Dietz DW, Pauer GJ, Rybicki LA, Conzone SD, Day DE (1999) Hepatic tumor radioemboli-zation in a rat model using radioactive rhenium (186Re/ 188Re) glass microspheres. Int J Radiat Oncol Biol Phys 44:189–199

    Article  PubMed  CAS  Google Scholar 

  22. Nijsen F, Rook D, Brandt C, Meijer R, Dullens H, Zonnenberg B, de Klerk J, van Rijk P, Hennink W, van het Schip F (2001) Targeting of liver tumour in rats by se-lective delivery of holmium-166 loaded microspheres: a biodistribution study. Eur J Nucl Med 28:743–749

    Article  PubMed  CAS  Google Scholar 

  23. Vuorela J, Kauppinen T, Sokka T (2005) Distribution of radiation in synovectomy of the knee with 166Ho-FHMA using image fusion. Cancer Biother Radiopharm 20:333–337

    Article  PubMed  CAS  Google Scholar 

  24. Yan L, Li L, Chen S (1996) Radioembolization with 32P-labelled glass microspheres for advanced hepatocellular carcinoma. Zhonghua Wai Ke Za Zhi 34:526–529

    PubMed  CAS  Google Scholar 

  25. Yan L, Li Z, Li L, Wang L, Lu W, Xie X, Liang Z (2000) The relationship between effects and radiation doses of intra-arterial phosphorus-32 glass microspheres embolization therapy for patients with advanced liver cancer. Chung-Hua Wai Ko Tsa Chih [Chinese Journal of Surgery] 38:837–840

    CAS  Google Scholar 

  26. Keng GH, Sundram FX, Yu SW, Somanesan S, Premaraj J, Oon CJ, Kwok R, Htoo MM (2002) Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates. Ann Acad Med Singapore 31:382–386

    PubMed  CAS  Google Scholar 

  27. Kumar A, Bal C, Srivastava DN, Thulkar SP, Sharma S, Acharya SK, Duttagupta S (2006) Management of multiple intrahepatic recurrences after radiofrequency ablation of hepatocellular carcinoma with rhenium-188-HDD-lipiodol. Eur J Gastroenterol Hepatol 18:219–223

    Article  PubMed  CAS  Google Scholar 

  28. Kumar A, Srivastava DN, Bal C (2006) Management of postsurgical recurrence of hepatocellular carcinoma with rhenium 188-HDD labeled iodized oil. J Vasc Interv Radiol 17:157–161

    PubMed  Google Scholar 

  29. Yoon CJ, Chung JW, Park JH, Kim YI, Lee KH, Jeong JM, Paeng JC (2004) Transcatheter arterial embolization with 188Rhenium-HDD-labeled iodized oil in rabbit VX2 liver tumor. J Vasc Interv Radiol 15:1121–1128

    PubMed  Google Scholar 

  30. Lin WY, Tsai SC, Hsieh JF, Wang SJ (2000) Effects of 90Y-microspheres on liver tumors: comparison of intra-tumoral injection method and intra-arterial injection method. J Nucl Med 41:1892–1897

    PubMed  CAS  Google Scholar 

  31. Yan ZP, Lin G, Zhao HY, Dong YH (1993) Yttrium-90 glass microspheres injected via the portal vein. An ex-perimental study. Acta Radiol 34:395–398

    Article  PubMed  CAS  Google Scholar 

  32. Tian JH, Xu BX, Zhang JM, Dong BW, Liang P, Wang XD (1996) Ultrasound-guided internal radiotherapy using yttrium-90-glass microspheres for liver malignancies. J Nucl Med 37:958–963

    PubMed  CAS  Google Scholar 

  33. Hafeli UO, Sweeney SM, Beresford BA, Humm JL, Macklis RM (1995) Effective targeting of magnetic radioactive 90Y-microspheres to tumor cells by an externally applied magnetic field. Preliminary in vitro and in vivo results. Nucl Med Biol 22:147–155

    Article  PubMed  CAS  Google Scholar 

  34. Hafeli UO, Sweeney SM, Beresford BA, Sim EH, Macklis RM (1994) Magnetically directed poly(lactic acid) 90Y-microspheres: novel agents for targeted intracavitary radiotherapy. J Biomed Mater Res 28:901–908

    Article  PubMed  CAS  Google Scholar 

  35. Rudge S, Peterson C, Vessely C, Koda J, Stevens S, Catterall L (2001) Adsorption and desorption of chemo-therapeutic drugs from a magnetically targeted carrier (MTC). J Control Release 74:335–340

    Article  PubMed  CAS  Google Scholar 

  36. Hernandez MC, Knox SJ (2003) Radiobiology of radioim-munotherapy with 90Y ibritumomab tiuxetan (Zevalin). Semin Oncol 30[6 Suppl 17]:6–10

    Article  PubMed  CAS  Google Scholar 

  37. Hernandez MC, Knox SJ (2004) Radiobiology of ra-dioimmunotherapy: targeting CD20 B-cell antigen in non-Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 59:1274–187

    PubMed  CAS  Google Scholar 

  38. Toegel S, Mien LK, Wadsak W, Eidherr H, Viernstein H, Kluger R, Ettlinger D, Kletter K, Dudczak R, Mitterhauser M (2006) In vitro evaluation of no carrier added, carrier added and cross-complexed [90Y]-EDTMP provides evidence for a novel „foreign carrier theory“. Nucl Med Biol 33:95–99

    Article  PubMed  CAS  Google Scholar 

  39. Araki N, Nagata Y, Fujiwara K, Aoki T, Mitsumori M, Kimura H, Itasaka S, Saitou H, Hiraoka M, Kawashita M, Kokubo T (2001) Evaluation of glass microspheres for intra-arterial radiotherapy in animal kidneys. Int J Radiat Oncol Biol Phys 49:459–463

    Article  PubMed  CAS  Google Scholar 

  40. Becker CD, Rosier H, Biasiutti FD, Baer HU (1995) Congestive hypersplenism: treatment by means of radioemboli-zation of the spleen with Y-90. Radiology 195:183–186

    PubMed  CAS  Google Scholar 

  41. Mulcahy MF, Benson AB 3rd (2005) Bevacizumab in the treatment of colorectal cancer. Expert Opin Biol Ther 5:997–1005

    Article  PubMed  CAS  Google Scholar 

  42. Stathopoulos GP, Rigatos SK, Stathopoulos JG, Xynotroulas JP, Dimou E (2005) Efficacy and tolerability of oxaliplatin plus irinotecan 5-fluouracil and leucovorin regimen in advanced stage colorectal cancer patients pretreated with irinotecan 5-fluouracil and leucovorin. Am J Clin Oncol 28:565–569

    Article  PubMed  CAS  Google Scholar 

  43. Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, Cardaci G, Gray B (2004) Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 88:78–85

    Article  PubMed  CAS  Google Scholar 

  44. Van Hazel G, Price D, Bower G, Blanshard KS, Steward WP, Sharma RA (2005) Selective internal radiation therapy (SIRT) plus systemic chemotherapy with FOLFOX4: a phase I dose escalation study. ASCO GI Symposium 2005, Miami, Florida

    Google Scholar 

  45. Van Hazel G, Price D, Bower G, Sharma RA, Blanshard K, Steward WP (2005) Selective internal radiation therapy (SIRT) for liver métastases with concomitant systemic oxaliplatin, 5-fluorouracil and folinic acid: a phase I/II dose escalation study. ASCO GI Symposium 2005, Miami, Florida

    Google Scholar 

  46. Coldwell D, Nutting C, Kennedy AK (2005) Treatment of hepatic métastases from breast cancer with yttrium-90 SIR-Spheres radioembolization. Society of Intervention-al Radiology Annual Meeting 2005, New Orleans, LA

    Google Scholar 

  47. Rubin D, Nutting C, Jones B (2004) Metastatic breast cancer in a 54-year-old woman: integrative treatment with yttrium-90 radioembolization. Integr Cancer Ther 3:262–267

    Article  PubMed  Google Scholar 

  48. Sharma RA, Van Hazel GA, Morgan B, Berry DP, Blanshard K, Price D, Bower G, Shannon JA, Gibbs P, Steward WP (2007) Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 25:1099–1106

    Article  PubMed  CAS  Google Scholar 

  49. Herscher LL, Cook JA, Pacelli R, Pass HI, Russo A, Mitchell JB (1999) Principles of chemoradiation: theo-retical and practical considerations. Oncology (Willis-ton Park) 13[10 Suppl 5]:ll–22

    Google Scholar 

  50. Coldwell D, Nutting C, Kennedy AK (2005) Use of yttrium-90 SirSpheres to treat metastatic unresectable neuroendocrine tumors to the liver. World Congress of Gastrointestinal Cancer 2005, Barcelona, Spain

    Google Scholar 

  51. Kennedy A, Coldwell D, Nutting C, Sailer S, Overton C (2005) Hepatic brachytherapy for GI neuroendocrine tumors with Y90 microspheres: long-term USA results. International Congress on Anti-Cancer Treatment 2005, Paris, France

    Google Scholar 

  52. Herba MJ, Thirlwell MP (2002) Radioembolization for hepatic metastases. Semin Oncol 29:152–159

    Article  PubMed  Google Scholar 

  53. Herba MJ, Illescas FF, Thirlwell MP, Boos GJ, Rosenthall L, Atri M, Bret PM (1988) Hepatic malignancies: improved treatment with intraarterial Y-90. Radiology 169:311–314

    PubMed  CAS  Google Scholar 

  54. Andrews JC, Walker SC, Ackermann RJ, Cotton LA, Ensminger WD, Shapiro B (1994) Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med 35:1637–1644

    PubMed  CAS  Google Scholar 

  55. Kim DY, Kwon DS, Salem R, Ma CK, Abouljoud MS (2006) Successful embolization of hepatocelluar carcinoma with yttrium-90 glass microspheres prior to liver transplantation. J Gastrointest Surg 10:413–416

    Article  PubMed  Google Scholar 

  56. Kulik LM, Atassi B, van Holsbeeck L, Souman T, Lewandowski RJ, Mulcahy MF, Hunter RD, Nemcek AA Jr, Abecassis MM, Haines KG 3rd, Salem R (2006) Yttrium-90 microspheres (TheraSphere(R)) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol 94:572–586

    Article  PubMed  CAS  Google Scholar 

  57. Lau WY, Ho SK, Yu SC, Lai EC, Liew CT, Leung TW (2004) Salvage surgery following downstaging of unresectable hepatocellular carcinoma. Ann Surg 240:299–305

    Article  PubMed  Google Scholar 

  58. Kennedy AS, Nutting C, Coldwell D, Gaiser J, Drachenberg C (2004) Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys 60:1552–1563

    PubMed  CAS  Google Scholar 

  59. Voboril R (2005) Blood supply of metastatic liver tumors: an experimental study. Int Surg 90:71–77

    PubMed  Google Scholar 

  60. Kennedy AS, Dezern W, McNeillie P, England M, Goldner K, Brooks L, Sailer S (2006) Dose selection of resin Y90 microspheres for liver brachytherapy: a single center review. American Brachytherapy Society 2006, Orlando, Florida

    Google Scholar 

  61. Rhee TK, Omary RA, Gates V, Mounajjed T, Larson AC, Barakat O, Sato KT, Mulcahy M, Gordon S, Lewandowski RJ, Salem R (2005) The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma. J Vasc Interv Radiol 16:1085–1091

    PubMed  Google Scholar 

  62. Kumar A, Srivastava DN, Chau TT, Long HD, Bal C, Chandra P, Chienle T, Hoa NV, Thulkar S, Sharma S, Tarn le H, Xuan TQ, Canh NX, Pant GS, Bandopadhyaya GP (2007) Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment-prospective multicenter clinical trial. Radiology 243:509–519

    Article  PubMed  Google Scholar 

  63. Avila-Rodriguez MA, Selwyn RG, Hampel JA, Thomadsen BR, Dejesus OT, Converse AK, Nickles RJ (2007) Positron-emitting resin microspheres as surrogates of (90)Y SIR-Spheres: a radiolabeling and stability study. Nucl Med Biol 34:585–590

    Article  PubMed  CAS  Google Scholar 

  64. Deng J, Miller FH, Rhee TK, Sato KT, Mulcahy MF, Kulik LM, Salem R, Omary RA, Larson AC (2006) Diffusionweighted. MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization. J Vasc Interv Radiol 17:1195–1200

    Article  PubMed  Google Scholar 

  65. Ho S, Lau WY, Leung TW, Chan M, Johnson PJ, Li AK (1997) Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med 24:293–298

    PubMed  CAS  Google Scholar 

  66. Keppke AL, Salem R, Reddy D, Huang J, Jin J, Larson AC, Miller FH (2007) Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres. AJR Am J Roentgenol 188:768–775

    Article  PubMed  Google Scholar 

  67. Miller FH, Keppke AL, Reddy D, Huang J, Jin J, Mulcahy MF, Salem R (2007) Response of liver m tastases after treatment with yttrium-90 microspheres: role of size, necrosis, and PET. AJR Am J Roentgenol 188:776–783

    Article  PubMed  Google Scholar 

  68. Wong CY, Qing F, Savin M, Campbell J, Gates VL, Sherpa KM, Lewandowski RJ, Nagle C, Salem R (2005) Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by [18F]fluorodeoxyglucose positron emission tomographic imaging. J Vasc Interv Radiol 16:1101–1106

    PubMed  Google Scholar 

  69. Wong CY, Salem R, Qing F, Wong KT, Barker D, Gates V, Lewandowski R, Hill EA, Dworkin HJ, Nagle C (2004) Metabolic response after intraarterial 90Y-glass micro-sphere treatment for colorectal liver metastases: comparison of quantitative and visual analyses by 18F-FDG PET. J Nucl Med 45:1892–1897

    PubMed  CAS  Google Scholar 

  70. Wong CY, Salem R, Raman S, Gates VL, Dworkin HJ (2002) Evaluating 90Y-glass microsphere treatment re-sponse of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI. Eur J Nucl Med Mol Imaging 29:815–820

    Article  PubMed  CAS  Google Scholar 

  71. Lin M, Shon IH, Wilson R, D’Amours SK, Schlaphoff G, Lin P (2007) Treatment response in liver metastases following 90Y SIR-spheres: an evaluation with PET. Hepa-togastroenterology 54:910–912

    CAS  Google Scholar 

  72. Lewandowski RJ, Alii A, Atassi B, Kulik L, Mulcahy MF, Salem R (2006) Retraction of portal vein thrombus following treatment with Y90 TheraSphere: a secondary sign of tumor response. Society of Interventional Radiology 2006, Toronto, Canada

    Google Scholar 

  73. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan. RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216

    Article  PubMed  CAS  Google Scholar 

  74. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430

    Article  PubMed  CAS  Google Scholar 

  75. Bienert M, McCook B, Carr BI, Geller DA, Sheetz M, Amesur N, Avril N (2005) Sequential FDG PET/CT in 90Y microsphere treatment of unresectable colorectal liver métastases. Eur J Nucl Med Mol Imaging 32:723

    Article  PubMed  Google Scholar 

  76. Bienert M, McCook B, Carr BI, Geller DA, Sheetz M, Tutor C, Amesur N, Avril N (2005) 90Y microsphere treatment of unresectable liver metastases: changes in 18F-FDG uptake and tumour size on PET/CT. Eur J Nucl Med Mol Imaging 32:778–787

    Article  PubMed  CAS  Google Scholar 

  77. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236

    Article  PubMed  Google Scholar 

  78. Salem R, Lewandowski R, Roberts C, Goin J, Thurston K, Abouljoud M, Courtney A (2004) Use of yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 15:335–345

    PubMed  Google Scholar 

  79. Kim W, Clark TW, Baum RA, Soulen MC (2001) Risk factors for liver abscess formation after hepatic chemoem-bolization. J Vasc Interv Radiol 12:965–968

    Article  PubMed  CAS  Google Scholar 

  80. Thomas KT, Bream PR Jr, Berlin J, Meranze SG, Wright JK, Chari RS (2004) Use of percutaneous drainage to treat hepatic abscess after radiofrequency ablation of metastatic pancreatic adenocarcinoma. Am Surg 70:496–499

    PubMed  Google Scholar 

  81. Geschwind JF, Kaushik S, Ramsey DE, Choti MA, Fishman EK, Kobeiter H (2002) Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors. J Vasc Interv Radiol 13:1163–1166

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Interventional Oncology, Robert H. Lurie Comprehensive Cancer, 676 N St Clair, Suite 800, Chicago, IL, 60611, USA

    Riad Salem MD, MBA (Professor, Director)

  2. Department of Radiology, Robert H. Lurie Comprehensive Cancer, Department of Radiology, 676 N St Clair, Suite 800, Chicago, IL, 60611, USA

    Saad Ibrahim MD, Bassel Atassi MD & Robert J. Lewandowski MD

Authors
  1. Riad Salem MD, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Saad Ibrahim MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bassel Atassi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert J. Lewandowski MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiology Clínica Universitaria, Universidad de Navarra, Avenida de Pio XII, 36, 31008, Pamplona, Spain

    José I. Bilbao PhD (Professor) (Professor)

  2. Department of Clinical Radiology, University Hospitals - Grosshadern and Innenstadt Ludwig-Maximilians-University of Munich, Marchioninistrasse 15, 81377, Munich, Germany

    Maximilian F. Reiser MD (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Salem, R., Ibrahim, S., Atassi, B., Lewandowski, R.J. (2008). Future Directions in Radioembolization. In: Bilbao, J.I., Reiser, M.F. (eds) Liver Radioembolization with 90Y Microspheres. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-35423-9_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-35423-9_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-35421-5

  • Online ISBN: 978-3-540-35423-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation